TB vaccines in clinical development

Tuberculosis (Edinb). 2016 Aug:99 Suppl 1:S16-20. doi: 10.1016/j.tube.2016.05.013. Epub 2016 Jun 16.

Abstract

The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on TB Vaccines in Clinical Development, and Clinical Research: Data and Findings. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1-S30].

Keywords: Clinical trial; Immunogenicity; Safety; TB vaccine.

Publication types

  • Congress

MeSH terms

  • Aerosols
  • Animals
  • BCG Vaccine / adverse effects
  • BCG Vaccine / immunology
  • BCG Vaccine / pharmacokinetics
  • Clinical Trials as Topic
  • Disease Models, Animal
  • Drug Delivery Systems
  • Drug Discovery
  • Guinea Pigs
  • Humans
  • Immunity, Cellular
  • Immunization, Secondary
  • Immunologic Memory / immunology
  • Tuberculosis / prevention & control*
  • Tuberculosis Vaccines / adverse effects
  • Tuberculosis Vaccines / immunology
  • Tuberculosis Vaccines / pharmacology*
  • Vaccines, Attenuated / adverse effects
  • Vaccines, Attenuated / immunology
  • Vaccines, Attenuated / pharmacology
  • Vaccines, Synthetic / adverse effects
  • Vaccines, Synthetic / immunology
  • Vaccines, Synthetic / pharmacology

Substances

  • Aerosols
  • BCG Vaccine
  • Tuberculosis Vaccines
  • Vaccines, Attenuated
  • Vaccines, Synthetic